China Oncology ›› 2023, Vol. 33 ›› Issue (6): 566-573.doi: 10.19401/j.cnki.1007-3639.2023.06.003
• Specialists' Commentary • Previous Articles Next Articles
ZHAO Qian(), LING Yunxiao, LIU Guangyu()
Received:
2022-12-12
Revised:
2023-05-15
Online:
2023-06-30
Published:
2023-07-26
CLC Number:
ZHAO Qian, LING Yunxiao, LIU Guangyu. Recent advances and perspectives in the application of repeat sentinel lymph node biopsy in breast cancer patients underwent breast-conserving surgery[J]. China Oncology, 2023, 33(6): 566-573.
Tab.1
Identification rate and axillary recurrence rate of rSLNB in different studies"
Study | Year | Patient number | Identification rate | Axillary recurrence rate | Median follow-up time t/month |
---|---|---|---|---|---|
Haarsma R, et al[ | 2022 | 119 | 79/119 (66.4%) | - | 58.8 |
Yoon C I, et al[ | 2020 | 495 | 356/495 (71.9%) | - | - |
Sávolt Á, et al[ | 2019 | 160 | 106/160 (66.3%) | - | - |
Poodt I G M, et al[ | 2018 | 1 687 | 1 091/1 687 (64.7%) | - | - |
Vugts G, et al[ | 2015 | 536 | 333/536 (62.1%) | - | - |
Intra M, et al[ | 2015 | 212 | 207/212 (97.6%) | 7/212 (3.3%) | 48.0 |
Maaskant-Braat A J, et al[ | 2013 | 692 | 452/692 (65.3%) | - | - |
Cox C E, et al[ | 2008 | 56 | 45/56 (80.4%) | 0/56 (0.0%) | - |
Intra M, et al[ | 2007 | 65 | 63/65 (96.9%) | 0/65 (0.0%) | 45.9 |
Port E R, et al[ | 2007 | 117 | 64/117 (54.7%) | 0/117 (0.0%) | - |
Intra M, et al[ | 2005 | 18 | 18/18 (100.0%) | 0/18 (0.0%) | 12.7 |
[1] |
HALSTED W S. I. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894[J]. Ann Surg, 1894, 20(5): 497-555.
doi: 10.1097/00000658-189407000-00075 |
[2] |
FISHER B, ANDERSON S, BRYANT J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16): 1233-1241.
doi: 10.1056/NEJMoa022152 |
[3] |
VERONESI U, CASCINELLI N, MARIANI L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med, 2002, 347(16): 1227-1232.
doi: 10.1056/NEJMoa020989 |
[4] |
BLICHERT-TOFT M, NIELSEN M, DÜRING M, et al. Long-term results of breast conserving surgery vs mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol[J]. Acta Oncol, 2008, 47(4): 672-681.
doi: 10.1080/02841860801971439 |
[5] |
LI Y, LI W W, YUAN L, et al. Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?[J]. Cancer, 2022, 128(22): 3919-3928.
doi: 10.1002/cncr.v128.22 |
[6] |
MO C Q, RUAN W H, LIN J Y, et al. Repeat breast-conserving surgery versus salvage mastectomy for ipsilateral breast tumour recurrence after breast-conserving surgery in breast cancer patients: a meta-analysis[J]. Front Oncol, 2021, 11: 734719.
doi: 10.3389/fonc.2021.734719 |
[7] |
QU F L, LIN C J, LIU Z B, et al. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?[J]. Breast Cancer Res Treat, 2022, 196(1): 97-109.
doi: 10.1007/s10549-022-06708-y |
[8] | HANNOUN-LEVI J M, GAL J, SCHIAPPA R, et al. 10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event[J]. Clin Transl Radiat Oncol, 2023, 38: 71-76. |
[9] |
VERONESI U, PAGANELLI G, VIALE G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J]. N Engl J Med, 2003, 349(6): 546-553.
doi: 10.1056/NEJMoa012782 |
[10] |
SCHWARTZ G F, GIULIANO A E, VERONESI U, et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania[J]. Cancer, 2002, 94(10): 2542-2551.
pmid: 12173319 |
[11] |
GIULIANO A E, KIRGAN D M, GUENTHER J M, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer[J]. Ann Surg, 1994, 220(3): 391-398; discussion: 398-401.
doi: 10.1097/00000658-199409000-00015 pmid: 8092905 |
[12] |
CAUDLE A S, CUPP J A, KUERER H M. Management of axillary disease[J]. Surg Oncol Clin N Am, 2014, 23(3): 473-486.
doi: 10.1016/j.soc.2014.03.007 pmid: 24882346 |
[13] |
KRAG D N, ANDERSON S J, JULIAN T B, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol, 2010, 11(10): 927-933.
doi: 10.1016/S1470-2045(10)70207-2 pmid: 20863759 |
[14] |
BILIMORIA K Y, BENTREM D J, HANSEN N M, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer[J]. J Clin Oncol, 2009, 27(18): 2946-2953.
doi: 10.1200/JCO.2008.19.5750 pmid: 19364968 |
[15] | YI M, GIORDANO S H, MERIC-BERNSTAM F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database[J]. Ann Surg Oncol, 2010, 17(3): 343-351. |
[16] |
GALIMBERTI V, COLE B F, ZURRIDA S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol, 2013, 14(4): 297-305.
doi: 10.1016/S1470-2045(13)70035-4 pmid: 23491275 |
[17] |
GIULIANO A E, HUNT K K, BALLMAN K V, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J]. JAMA, 2011, 305(6): 569-575.
doi: 10.1001/jama.2011.90 |
[18] |
GIULIANO A E, MCCALL L, BEITSCH P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial[J]. Ann Surg, 2010, 252(3): 426-432; discussion 432-433.
doi: 10.1097/SLA.0b013e3181f08f32 pmid: 20739842 |
[19] | ALSUNITAN R I, AL-SAIF A, ALYOUSEF B A, et al. Axillary recurrence in breast cancer patients after negative sentinel lymph node biopsy: retrospective cohort study from Riyadh, Saudi Arabia[J]. Cureus, 2021, 13(12): e20132. |
[20] | KILUK J V, LY Q P, MEADE T, et al. Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up[J]. Ann Surg Oncol, 2011, 18(Suppl 3): S339-S342. |
[21] |
POLETTI P, FENAROLI P, MILESI A, et al. Axillary recurrence in sentinel lymph node-negative breast cancer patients[J]. Ann Oncol, 2008, 19(11): 1842-1846.
doi: 10.1093/annonc/mdn393 pmid: 18550574 |
[22] |
KILUK J V, LY Q P, SANTILLAN A A, et al. Erratum to: axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up[J]. Ann Surg Oncol, 2010, 17(2): 552-557.
doi: 10.1245/s10434-009-0800-2 pmid: 19957043 |
[23] |
LYMAN G H, GIULIANO A E, SOMERFIELD M R, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J]. J Clin Oncol, 2005, 23(30): 7703-7720.
doi: 10.1200/JCO.2005.08.001 pmid: 16157938 |
[24] | 郭瑢, 李伦, 张琪, 等. 中国乳腺癌前哨淋巴结活检现状调查研究[J]. 中国癌症杂志, 2020, 30(3): 166-173. |
GUO R, LI L, ZHANG Q, et al. Current status of sentinel lymph node biopsy for breast cancer in China: a cross-sectional study?[J]. China Oncol, 2020, 30(3): 166-173. | |
[25] | ZGAJNAR J, GATZEMEIER W, COSTA A. Will the sentinel lymph node (SLN) stand a second time: SLN biopsy in breast cancer patients with isolated local recurrence following breast conserving therapy and previous SLN procedure[J]. Ann Oncol, 2001, 12(5): 723. |
[26] |
CHUNG M A, CADY B. Caution urged with repeat sentinel lymph node biopsies[J]. Ann Oncol, 2002, 13(12): 1951.
pmid: 12453867 |
[27] |
INTRA M, TRIFIRÒ G, VIALE G, et al. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy[J]. Ann Surg Oncol, 2005, 12(11): 895-899.
pmid: 16195833 |
[28] |
STELZNER F, FRIEDRICHS N, BÜTTNER R, et al. Lymph vascularity and lymph node metastases on PET and PET/CT: immunohistological and clinical observations[J]. Chirurg, 2005, 76(5): 493-500.
doi: 10.1007/s00104-005-1015-0 |
[29] |
REES W V, ROBINSON D S, HOLMES E C, et al. Altered lymphatic drainage following lymphadenectomy[J]. Cancer, 1980, 45(12): 3045-3049.
pmid: 7388748 |
[30] |
VUGTS G, MAASKANT-BRAAT A J, VOOGD A C, et al. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer[J]. Breast Cancer Res Treat, 2015, 153(3): 549-556.
doi: 10.1007/s10549-015-3571-4 |
[31] |
POODT I G M, VUGTS G, SCHIPPER R J, et al. Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence: a systematic review of the results and impact on prognosis[J]. Ann Surg Oncol, 2018, 25(5): 1329-1339.
doi: 10.1245/s10434-018-6358-0 pmid: 29468606 |
[32] |
SÁVOLT Á, CSERNI G, LÁZÁR G, et al. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer[J]. Eur J Surg Oncol, 2019, 45(10): 1835-1838.
doi: S0748-7983(19)30454-8 pmid: 31126680 |
[33] |
KARAM A, STEMPEL M, CODY H S 3rd, et al. Reoperative sentinel lymph node biopsy after previous mastectomy[J]. J Am Coll Surg, 2008, 207(4): 543-548.
doi: 10.1016/j.jamcollsurg.2008.06.139 |
[34] |
COX C E, FURMAN B T, KILUK J V, et al. Use of reoperative sentinel lymph node biopsy in breast cancer patients[J]. J Am Coll Surg, 2008, 207(1): 57-61.
doi: 10.1016/j.jamcollsurg.2008.01.017 |
[35] |
INTRA M, TRIFIRÒ G, GALIMBERTI V, et al. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence[J]. Br J Surg, 2007, 94(10): 1216-1219.
pmid: 17583891 |
[36] |
INTRA M, VIALE G, VILA J, et al. Second axillary sentinel lymph node biopsy for breast tumor recurrence: experience of the European institute of oncology[J]. Ann Surg Oncol, 2015, 22(7): 2372-2377.
doi: 10.1245/s10434-014-4282-5 pmid: 25515197 |
[37] |
MAASKANT-BRAAT A J, VOOGD A C, ROUMEN R M, et al. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature[J]. Breast Cancer Res Treat, 2013, 138(1): 13-20.
doi: 10.1007/s10549-013-2409-1 |
[38] |
HAARSMA R, VAN LOEVEZIJN A A, DONSWIJK M L, et al. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence[J]. Breast Cancer Res Treat, 2022, 194(3): 617-627.
doi: 10.1007/s10549-022-06654-9 |
[39] |
YOON C I, AHN S G, KIM D, et al. Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence after breast conserving surgery with sentinel lymph node biopsy: pooled analysis using data from a systematic review and two institutions[J]. Front Oncol, 2020, 10: 518568.
doi: 10.3389/fonc.2020.518568 |
[40] |
PORT E R, GARCIA-ETIENNE C A, PARK J, et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence[J]. Ann Surg Oncol, 2007, 14(8): 2209-2214.
pmid: 17268882 |
[41] |
SCHRENK P, TAUSCH C, WAYAND W. Lymphatic mapping in patients with primary or recurrent breast cancer following previous axillary surgery[J]. Eur J Surg Oncol, 2008, 34(8): 851-856.
doi: 10.1016/j.ejso.2007.11.006 pmid: 18162358 |
[42] |
MAASKANT-BRAAT A J, ROUMEN R M, VOOGD A C, et al. Sentinel node and recurrent breast cancer (SNARB): results of a nationwide registration study[J]. Ann Surg Oncol, 2013, 20(2): 620-626.
doi: 10.1245/s10434-012-2625-7 |
[43] |
JACKSON B M, KIM S, DAVIDSON R, et al. Repeat operative sentinel lymph node biopsy[J]. Clin Breast Cancer, 2006, 6(6): 530-532.
pmid: 16595037 |
[44] | VUGTS G, MAASKANT-BRAAT A J, VOOGD A C, et al. Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer[J]. Ann Surg Oncol, 2015, 22(suppl 3): S529-S535. |
[45] |
GURU S D, HOSKIN T L, WHALEY D H, et al. Repeat sentinel lymph node surgery in recurrent breast cancer: peritumoral vs periareolar injections[J]. Clin Breast Cancer, 2021, 21(5): 466-476.
doi: 10.1016/j.clbc.2021.02.004 |
[46] |
VICINI E, LEONARDI M C, FONTANA S K R, et al. How to perform repeat sentinel node biopsy safely after a previous mastectomy: technical features and oncologic outcomes[J]. Ann Surg Oncol, 2022, 29(3): 1750-1760.
doi: 10.1245/s10434-021-10986-z |
[47] |
POODT I G M, VUGTS G, MAASKANT-BRAAT A J G, et al. Risk of regional recurrence after negative repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence[J]. Ann Surg Oncol, 2018, 25(5): 1312-1321.
doi: 10.1245/s10434-018-6384-y pmid: 29497910 |
[48] | 中国抗癌协会. 乳腺癌前哨淋巴结活检规范化操作指南(2022精要版)[J]. 中国肿瘤临床, 2022, 49(22): 1135-1142. |
China Anti-Cancer Association. Guidelines for standardized practice of sentinel lymph node biopsy in breast cancer (2022 abridged version)[J]. Chin J Clin Oncol, 2022, 49(22): 1136-1142. | |
[49] |
VOOGD A C, VAN OOST F J, RUTGERS E J, et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer[J]. Eur J Cancer, 2005, 41(17): 2637-2644.
pmid: 16115758 |
[50] |
POODT I G M, VUGTS G, SCHIPPER R J, et al. Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence[J]. Br J Surg, 2019, 106(5): 574-585.
doi: 10.1002/bjs.11097 pmid: 30908615 |
[51] |
AEBI S, GELBER S, ANDERSON S J, et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial[J]. Lancet Oncol, 2014, 15(2): 156-163.
doi: 10.1016/S1470-2045(13)70589-8 pmid: 24439313 |
[52] |
LEE J H, LEE S K, PARK S M, et al. Independent prognostic factors for overall survival after salvage operation for ipsilateral breast tumor recurrence following breast-conserving surgery[J]. J Breast Cancer, 2015, 18(4): 386-393.
doi: 10.4048/jbc.2015.18.4.386 pmid: 26770246 |
[53] |
VOOGD A C, VAN TIENHOVEN G, PETERSE H L, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch study group on local recurrence after breast conservation (BORST)[J]. Cancer, 1999, 85(2): 437-446.
doi: 10.1002/(sici)1097-0142(19990115)85:2<437::aid-cncr23>3.0.co;2-1 pmid: 10023713 |
[54] |
UGRAS S, MATSEN C, EATON A, et al. Reoperative sentinel lymph node biopsy is feasible for locally recurrent breast cancer, but is it worthwhile?[J]. Ann Surg Oncol, 2016, 23(3): 744-748.
doi: 10.1245/s10434-015-5003-4 pmid: 26644258 |
[55] |
ALPERT T E, KUERER H M, ARTHUR D W, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs salvage breast-conserving surgery and prognostic factors for salvage breast preservation[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3): 845-851.
doi: 10.1016/j.ijrobp.2005.02.035 |
[56] | GROHEUX D, COCHET A, HUMBERT O, et al. 18F-FDG PET/CT for staging and restaging of breast cancer[J]. J Nucl Med, 2016, 57(suppl 1): 17-26. |
[57] |
KRAMMER J, SCHNITZER A, KAISER C G, et al. 18F-FDG PET/CT for initial staging in breast cancer patients-is there a relevant impact on treatment planning compared to conventional staging modalities?[J]. Eur Radiol, 2015, 25(8): 2460-2469.
doi: 10.1007/s00330-015-3630-6 |
[1] | WANG Ruoxi, JI Peng, GONG Yue, CHEN Sheng. Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study [J]. China Oncology, 2023, 33(7): 686-692. |
[2] | WU Siyu, LI Junjie, SHAO Zhimin. Development history and research progress of sentinel lymph node biopsy in breast cancer [J]. China Oncology, 2023, 33(6): 551-559. |
[3] | BI Zhao, WANG Yongsheng. New concept of de-escalation management strategy in breast cancer patients with 1-2 positive sentinel lymph nodes [J]. China Oncology, 2023, 33(6): 560-565. |
[4] | CONG Binbin, CAO Xiaoshan, WANG Chuanjian, QIU Pengfei, SUN Xiao, CHEN Peng, LIU Yanbing, ZHAO Tong, ZHANG Zhaopeng, SHI Zhiqiang, BI Zhao, WANG Yongsheng. Feasibility analysis of sentinel lymph node biopsy in breast cancer with axilla negative evaluation by physical examination but suspicious lymph nodes finding on preoperative imaging and metastasis confirmed with biopsy [J]. China Oncology, 2023, 33(6): 574-580. |
[5] | REN Hengyu, HAO Shuang, CHEN Jiajian, YANG Benlong, CAO Ayong, LIU Guangyu, SHAO Zhimin, WU Jiong. Current status and focus of breast reconstruction research in China and abroad: a bibliometric study [J]. China Oncology, 2023, 33(6): 581-588. |
[6] | CHEN Luyan, WANG Lixue, FU Peifen. The value of surgery in the patients with de novo stage Ⅳ breast cancer [J]. China Oncology, 2023, 33(5): 431-436. |
[7] | YANG Wenxiao, GUO Linwei, LING Hong, HU Xin. Characterization of immune microenvironment identifies prognostic and immunotherapy benefit for trastuzumab-based therapy [J]. China Oncology, 2023, 33(5): 484-498. |
[8] | CHEN Junyao, ZHANG Wentao, LIU Qiao, NIE Jianyun. Clinical dilemma and systemic treatment strategy of triple-negative breast cancer in the elderly [J]. China Oncology, 2023, 33(5): 506-516. |
[9] | CHEN Hong, CHEN Junxia. Effect of hsa_circ_0001573 on biological behaviors of breast cancer cells and its molecular mechanism [J]. China Oncology, 2023, 33(4): 342-353. |
[10] | BI Zhao, CHEN Peng, QIU Pengfei, CHEN Yuguang, WANG Yongsheng. The analysis of axillary lymph nodes metastasis after neoadjuvant therapy in breast cancer [J]. China Oncology, 2023, 33(4): 361-367. |
[11] | CAO Xiaoshan, CONG Binbin. The research progress of endocrine therapy combined with targeted therapy for triple-positive breast cancer [J]. China Oncology, 2023, 33(3): 288-292. |
[12] | SHAO Zhibo, YANG Benlong, WU Jiong. Progress of important clinical trials of breast cancer in China in 2022 [J]. China Oncology, 2023, 33(2): 103-109. |
[13] | ZHANG Huiqiang, JIANG Zefei. Key clinical studies on changing clinical practice of advanced breast cancer in 2022 [J]. China Oncology, 2023, 33(2): 110-116. |
[14] | YANG Benlong, JIAO Dechuang, CHEN Jiajian, WANG Chunjian, JIN Lidan, ZHAO Wenhe, GAO Xueqiang, WANG Haibo, LI Jun, ZHAO Haidong, WU Di, FAN Zhimin, WANG Shujun, LIU Zhenzhen, WANG Yongsheng, WU Jiong. Compared the efficacy of mitoxantrone hydrochloride injection for tracing with radionuclide in sentinel lymph node biopsy of breast cancer [J]. China Oncology, 2023, 33(2): 126-133. |
[15] | DUAN Baowei, ZHAO Na, BI Zhao, QIU Pengfei, XU Xinghe, CHEN Yuguang, FAN Qingda, WANG Yongsheng. Radiotracer technique optimization for breast cancer internal mammary sentinel lymph node biopsy [J]. China Oncology, 2023, 33(2): 134-141. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
沪ICP备12009617
Powered by Beijing Magtech Co. Ltd